MSH2 and neoplasm: Current studies indicate that both germline and somatic mutations in MSH2, MSH6, and MLH1, including those associated with aggressive histological variants, are linked to EC, whereas abnormalities in MSH3, MLH3, and EXO1 may indirectly facilitate tumor progression through genomic instability or cell cycle dysregulation (Table 1).